NRS 439B.640
Manufacturer of essential diabetes drug that has undergone significant price increase to submit report.

On or before April 1 of a year in which a drug is included on the list compiled pursuant to subsection 2 of NRS 439B.630, the manufacturer of the drug shall submit to the Department a report describing the reasons for the increase in the wholesale acquisition cost of the drug described in that subsection. The report must include, without limitation:

1.

A list of each factor that has contributed to the increase;

2.

The percentage of the total increase that is attributable to each factor;

3.

An explanation of the role of each factor in the increase; and

4.

Any other information prescribed by regulation by the Department.

Source: Section 439B.640 — Manufacturer of essential diabetes drug that has undergone significant price increase to submit report., https://www.­leg.­state.­nv.­us/NRS/NRS-439B.­html#NRS439BSec640.

439B.600
Definitions. 439B.605
“Manufacturer” defined. 439B.610
“Pharmacy” defined. 439B.615
“Pharmacy benefit manager” defined. 439B.620
“Wholesale acquisition cost” defined. 439B.625
Organization representing interests of retail merchants to prepare and update list of most commonly prescribed drugs or generic equivalents. 439B.630
Department to annually compile lists of certain prescription drugs essential for treating asthma and diabetes. 439B.635
Manufacturer of certain essential diabetes drugs to prepare and submit annual report. 439B.640
Manufacturer of essential diabetes drug that has undergone significant price increase to submit report. 439B.645
Pharmacy benefit manager to submit annual report concerning essential diabetes drugs. 439B.650
Department to compile report concerning price of essential asthma and diabetes drugs. 439B.655
Pharmacies to provide to Department contact information, electronic mail address and address of Internet website 439B.660
Manufacturer required to provide list of its pharmaceutical sales representatives 439B.665
Report by certain nonprofit organizations that receive items of value from manufacturer. 439B.670
Department to place on Internet website certain information concerning pharmacies, nonprofit organizations and prescription drugs and certain reports by Department 439B.675
Manner of presentation of information. 439B.680
Immunity from civil and criminal liability. 439B.685
Regulations. 439B.690
Suspension of components of program or duties of Department if sufficient money not available 439B.695
Penalty for failure to provide information to Department.
Last Updated

Feb. 5, 2021

§ 439B.640’s source at nv​.us